Biocept and protean biodiagnostics establish research collaboration to demonstrate advantages of biocept's target selector™ assay kit for non-small cell lung cancer patients

San diego--(business wire)--biocept and protean biodiagnostics collaborate to demonstrate advantages of biocept's target selector assay for non-small cell lung cancer patients.

BIOC Ratings Summary

BIOC Quant Ranking